CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Amerisource Health Services LLC recalls Duloxetine Delayed-Release…

Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules and 1 more

Read the official FDA notice

Published
1 Jan 2025
Units affected
4 products
Agency
FDA
Country
United States

The hazard

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-05

Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04

Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04

Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08

Brand / company
Amerisource Health Services LLC
Codes / lots
Lot DT3023030A Exp 2/28/2025 | Lot DT3023029A Exp 02/28/2025 | Lot DT6023061B Exp 01/31/2025 | Lots, expiry: Lot DT6022166A, exp 11/30/2024; Lot DT6023071A, exp 2/28/2025
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 1 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.